Vela, Thomas Jefferson collaborate on assay development

01/31/2013 | GenomeWeb Daily News (free registration)

Singapore's Vela Diagnostics and the Thomas Jefferson University and Hospitals in Philadelphia entered into an agreement to co-develop molecular diagnostic assays for cancer and infectious diseases. Thomas Jefferson will help validate the tests. Vela will be in charge of regulatory filings.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC